Informative censoring of surrogate end-point data in phase 3 oncology trials
Shai Gilboa, Yarden Pras, Aviv Mataraso, David Bomze, Gal Markel, Tomer Meirson
Topics & Concepts
Censoring (clinical trials)MedicineSurrogate endpointClinical trialHazard ratioClinical endpointSurvival analysisInternal medicineEnd pointRandomized controlled trialOncologyProportional hazards modelConfidence intervalPathologyMathematicsGeometryAdvanced Causal Inference TechniquesStatistical Methods in Clinical TrialsEthics in Clinical Research